A new adjunctive treatment (Diamox, X-GEN Pharmaceuticals) is being marketed for open-angle glaucoma, secondary glaucoma, and preoperatively acute angle-closure glaucoma where delay of surgery is desired in order to lower IOP.
The journal page you requested is now available only to registered Modern Medicine members.
Source: Ophthalmology Times,
12/24/2008 Click here